期刊文献+

中西医结合治疗难治性胃食管反流病的优势 被引量:8

Exploration on the Superiorities of Integrative Medicine for Treating Refractory Gastroesophageal Reflux Disease
原文传递
导出
摘要 胃食管反流病(GERD)作为消化科常见病,具有高发病率、全年龄层覆盖、病因复杂等特点。尽管质子泵抑制剂(PPIs)是GERD的首选治疗药物,但是高达30%患者对足量PPIs治疗应答较差,表现为难治性GERD(rGERD)。在西医客观证据和中医病证结合思想的指导下,中西医结合治疗可弥补单纯抑酸疗法对rGERD弱酸、非酸反流以及功能性胃肠病重叠症状等治疗的不足,具有提高治疗有效率,减轻长期服用PPIs所致不良反应,降低疾病复发率等优势。 Gastroesophageal reflux disease(GERD)is a common disease in Gastroenterology Department,which has the characteristics of high incidence,covering all ages groups,and complex etiology.Although proton pump inhibitors(PPIs)are the first treatment choice for GERD,up to 30%of patients are refractory to treatment with a poor response to full dose therapy(refractory GERD,rGERD).Under the guidance of the objective evidence of Western medicine and the thought of combining symptoms and syndromes of Chinese medicine,integrative Chinese and Western medicine treatment can make up for the deficiency of suppressive therapy alone,weak acid and non-acid reflux of rGERD and overlapping symptoms of functional gastrointestinal diseases.It improved the treatment efficiency.Adverse reactions caused by long-term use of PPIs could be reduced.And its recurrence rate were also reduced.
作者 张泰 张北华 马祥雪 王凤云 唐旭东 ZHANG Tai;ZHANG Bei-hua;MA Xiang-xue;WANG Feng-yun;TANG Xu-dong(Department of Gastroenterology,Xiyuan Hospital,China Academy of Chinese Medical Sciences,Beijing 100091;Graduate School,China Academy of Chinese Medical Sciences,Beijing 100700;China Academy of Chinese Medical Sciences,Beijing 100700)
出处 《中国中西医结合杂志》 CAS CSCD 北大核心 2022年第9期1124-1131,共8页 Chinese Journal of Integrated Traditional and Western Medicine
基金 国家重点研发计划项目(No.2019YFC1709600) 中国中医科学院科技创新工程(No.CI2021A01001) 国家自然科学基金青年项目(No.82004356)。
关键词 难治性胃食管反流病 中西医结合治疗 优势 refractory gastroesophageal reflux disease integrative medical treatment superiority
  • 相关文献

参考文献30

二级参考文献257

共引文献1133

同被引文献107

引证文献8

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部